Prenosis
Prenosis develops diagnostics and decision-support tools for acute care by linking biospecimen collections to longitudinal clinical records and applying machine learning to biomarker and EMR data. The company performs biomarker discovery and validation studies, operates cloud-hosted clinical data platforms for model development, integrates decision support into hospital workflows and EHR systems, publishes peer‑reviewed research, and pursues regulatory and reimbursement pathways for clinical deployment.
Industries
Nr. of Employees
small (1-50)
Prenosis
Patents
Microfluidic cartridge and stacked testing assembly with microfluidic cartridge thereof
US-11027274-B2
View Details
Microfluidic cartridge and stacked testing assembly with microfluidic cartridge thereof
US-11027274-B2
View DetailsProducts
Regulatory‑authorized AI sepsis risk diagnostic
A clinician‑facing diagnostic that combines multivariate biomarker inputs and clinical data to stratify sepsis risk and predict short‑term outcomes; designed for near‑real‑time delivery within hospital workflows and EHRs.
Precision‑medicine platform for acute care (biobank + data linkage)
A platform that links biomarker assays, a biospecimen repository, and longitudinal clinical data to support discovery, model development, validation, and deployment of diagnostics and trial‑enabling tools for acute illnesses.
Sepsis ImmunoScore
The first-ever FDA authorized AI sepsis diagnostic leveraging biomarkers, clinical data, and AI to holistically evaluate a patient’s chances of experiencing adverse outcomes within 24 hours.
Immunix
Precision medicine platform utilizing AI and a comprehensive biological dataset to generate deep understanding of patient immune response and enable new precision medicine products and optimized care.
Regulatory‑authorized AI sepsis risk diagnostic
A clinician‑facing diagnostic that combines multivariate biomarker inputs and clinical data to stratify sepsis risk and predict short‑term outcomes; designed for near‑real‑time delivery within hospital workflows and EHRs.
Precision‑medicine platform for acute care (biobank + data linkage)
A platform that links biomarker assays, a biospecimen repository, and longitudinal clinical data to support discovery, model development, validation, and deployment of diagnostics and trial‑enabling tools for acute illnesses.
Sepsis ImmunoScore
The first-ever FDA authorized AI sepsis diagnostic leveraging biomarkers, clinical data, and AI to holistically evaluate a patient’s chances of experiencing adverse outcomes within 24 hours.
Immunix
Precision medicine platform utilizing AI and a comprehensive biological dataset to generate deep understanding of patient immune response and enable new precision medicine products and optimized care.
Services
Integration of diagnostic outputs and decision‑support tools into hospital electronic health records and clinical documentation workflows.
Platform deployment and operational support at clinical sites to accelerate identification and enrollment for biomarker‑stratified and randomized trials.
Design and operation of cloud-hosted clinical data pipelines, warehouses, and analytics platforms to support model development, validation, and deployment.
Integration of diagnostic outputs and decision‑support tools into hospital electronic health records and clinical documentation workflows.
Platform deployment and operational support at clinical sites to accelerate identification and enrollment for biomarker‑stratified and randomized trials.
Design and operation of cloud-hosted clinical data pipelines, warehouses, and analytics platforms to support model development, validation, and deployment.
Expertise Areas
- AI-driven diagnostic development and clinical validation
- Proteomics and biomarker discovery
- Multimodal data integration (biomarker + EMR) for phenotyping
- Clinical trial site deployment and biomarker‑guided enrollment
Key Technologies
- Machine learning and AI
- Explainable AI (SHAP-style interpretability)
- Proteomics and multivariate biomarker assays
- Multi-omics data integration
News & Updates
Company activity and content supporting World Sepsis Day and awareness of sepsis signs and symptoms.
Company support and educational outreach for Sepsis Alliance and Sepsis Awareness Month.
Event on how biomarkers and AI assist in sepsis diagnosis and prediction of adverse outcomes.
Team participation and presentations at a respiratory and critical care scientific conference.
Peer‑reviewed publication describing development and validation of an AI/ML sepsis prediction tool and its diagnostic performance.
Article describing use of SHAP‑based methods to improve interpretability of an AI sepsis diagnostic.
Company activity and content supporting World Sepsis Day and awareness of sepsis signs and symptoms.
Company support and educational outreach for Sepsis Alliance and Sepsis Awareness Month.
Event on how biomarkers and AI assist in sepsis diagnosis and prediction of adverse outcomes.
Team participation and presentations at a respiratory and critical care scientific conference.
Peer‑reviewed publication describing development and validation of an AI/ML sepsis prediction tool and its diagnostic performance.
Article describing use of SHAP‑based methods to improve interpretability of an AI sepsis diagnostic.